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Nuclear medicine pioneered image fusion decades ago, as
we can see from the dual isotope studies, where different infor-
mation concerning two independent processes could be extract-
ed from a single image. This approach was seldom exploited cli-
nically and is still only used by a very small proportion of centres,
predominantly for the simultaneous assessment of myocardial
perfusion and viability by heavy collimated SPECT, using 99mTc-
-based perfusion tracers and 18F-fluorodeoxyglucose (FDG) as
a marker of metabolism.
During the last decade, the rapid development of computer
science has enabled three essential methods of manipulating two
different tomographic datasets:
 registration, i.e. the fitting of one dataset onto another;
 normalisation for appropriate scaling;
 fusion for displaying.
Free software called Statistical Parametric Mapping [1] be-
came the informal standard for image registration and the analy-
sis of brain studies within the same modality for research purpo-
ses, while Hermes software by Nuclear Diagnostics introduced
the possibility of image fusion of different modalities to the broad
clinical community. Nowadays, all vendors offer powerful software
for image fusion, allowing nuclear medicine to overcome its major
limitation  the lack of anatomical detail, as well as poor spatial
resolution. Brain and oncological studies are the primary substrate
for today’s fusions. Further progress in promoting widespread
image fusion is currently being supported by inline hybrid PET/CT
and SPECT/CT scanners.
Unlike oncology or neurology, nuclear cardiology still remains
aloof from image fusion, even though the comparison of two datasets
(stress/rest) comprises its daily bread and butter. However, another
approach is exploited here: the analysis of datasets and the detec-
tion of structures such as left ventricle axes and endo- and epicardial
surfaces. Rather than image fusion, statistical comparison of extracted
corresponding structures is performed after normalisation. Despite
this, there are a few situations where image fusion can be helpful.
Some aspects of these will be discussed below.
Technical considerations: The general problem facing cardiac
acquisition by any modality is motion: the movement of the heart
during its cycle as well as respiratory movement. All modalities
use ECG gated acquisition to record the cardiac cycle. MRI and
CT are able to manage acquisition while the breath is being held,
while SPECT and PET are not. A theoretical solution (two-way
gating by ECG as well as by breathing signals) is not currently
applied in practice to SPECT and PET scanning. Identical prob-
lems such as the motion during acquisition must be treated du-
ring registration and image fusion. When registering PET or SPECT
(typically not gated) with MRI or CT (typically gated and at breath
hold), one must expect rather more blurry PET and SPECT ima-
ges and their suboptimal alignment with CT and MRI.
There are few examples of clinically relevant cardiological im-
age fusion: Cardiac neoplasm is an extremely rare condition, which
FDG-PET has a strong potential to discover, but insufficient ana-
tomical details limit this method. When MRI is available, the com-
parison of both investigations and even image fusion can increase
diagnostic certainty (Figure 1), but due to the low frequency of
these tumours, this type of fusion will never become routine.
Infectious endocarditis is unlikely to form masses detectable
by contemporary PET scanners. To our knowledge, only one
example has been reported in literature [2], when image fusion of
FDG-PET with CT detected infection of an aortic valve replace-
ment. This is promising information for the future, when one can
expect the increasing spatial resolution of PET scanners and two-
-way gated acquisition using ECG as well as respiration. Image
fusion with contrast enhanced CT will be mandatory in these cas-
Figure 1A. High FDG uptake in the mediastinum shows a suspected
neoplasm. PET alone is hardly able to localise that focus.
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Figure 3A. Volume rendering technique (VRT) showing the left anterior
descendent coronary artery and its branches acquired by 16 rows of de-
tector cCTA. Orange arrows point out stenoses of the left anterior de-
scendent artery (LAD) and its diagonal branch, the yellow arrow points to
calcification and the green arrow points out the prestenotic dilatation.
Figure 3B. A 3D model of perfusion of the left ventricle in the same pa-
tient in a similar orientation to that of Figure 3A in stress and rest condi-
tions (attenuation corrected SPECT). The area of significant stress hy-
poperfusion is picked out in black.
Figure 3C. Because of the lack of software for suitable visualisation of
fused cCTA and perfusion SPECT, we can only make a collage of Figure 3A
and Figure 3B using a graphic editor (Corel Photo-Paint 9). This example
urges real image fusion, because there is uncertainty over whether the
hypoperfusion is only caused by tight stenosis of the diagonal branch
(a probable misalignment of the collage). On the other hand, conspicuous
multiple stenoses of LAD exert a minimal impact on perfusion (probably
due to collateral flow). Appropriate visualisation of a true fusion could
elucidate these doubts.
Figure 1B. A plane along the vertical long axis of the left ventricle by
PET (left), what is known as a two-chamber projection by MRI (TSE T2
FAT SAT) on the right hand side and their fusion in the middle. MRI
alone or its image fusion with PET enables localisation of the tumour
into the lower wall of left atrium. Rhabdomyosarcoma was approved
histologically.
Figure 2B. On the other hand when fusing the FDG-PET functional
image (right) with the inversion recovery post contrast MRI anatomi-
cal image (left), the fused image (middle) could be easily assessed.
Note that more details are visible from MRI that correspond excel-
lently to the perfusion/metabolic images in Figure 2A: no or minimal
contrast enhancement in the basal part of the anterior wall (green
arrow) is typical of a viable myocardium; the clear rim of contrast en-
hancement in the apical 2/3 of the anterior wall represents a suben-
docardial scar (blue arrow), while the subepicardial myocardium is
still viable and hibernating (white arrow); transmural deposits of the
contrast medium in the apex (yellow arrow) represent nonviable my-
ocardium (white arrowhead).
Figure 2A. A vertical long axis plane of the left ventricle: Substantial hy-
poperfusion is clearly apparent in the apex and apical half of the anterior
wall (green arrows on the left hand side). In the same region one can rec-
ognize glucose hypermetabolism (white arrow) representing a viable hi-
bernating myocardium as well as hypometabolism (arrowhead on the
right hand side) representing a nonviable myocardial scar. The image
fusion in the middle is difficult to assess, because both modalities are of
similar spatial resolution. All images are attenuation corrected; the quality
of the FDG-PET is lower because of the generally low glucose myocardial
uptake in a diabetic.
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es. Variable physiological FDG uptake in the myocardium will pro-
bably limit hybrid investigation to valvular involvement alone.
Myocardial viability can be traditionally assessed by metabo-
lic FDG-PET in combination with either NH3-PET or sestamibi/
/tetrofosmin SPECT perfusion studies. In a clinical setting, the dis-
play of three perpendicular planes, which intersect the axes of the
left ventricle, is used in parallel for both investigations. Visual anal-
ysis of these images is usually sufficient. Semi-quantitative as-
sessment known from cardiac software packages for stress/rest
perfusion studies is seldom used. Image fusion of perfusion/met-
abolic information is not used because it is of little benefit. More-
over, as the fusion of perfusion and metabolic information com-
prises the superposition of two blurred images, they are almost
impossible to assess (Figure 2A).
The most advantageous method of image fusion is the combi-
nation of a sharp anatomical modality (MRI or CT) in a black and
white scale, with a blurred functional one (PET or SPECT) in a so-
called hot body or hot iron colour scale (Figure 2B). Nowadays
MRI can produce more detailed information about myocardial viabil-
ity and other cardiac pathology [3], even without the radiation bur-
den, than the two (perfusion/metabolic) studies provided by nuclear
medicine. This means that there is probably no future for this type of
fusion becoming routine, even though it would be very interesting.
Stress/rest myocardial perfusion scintigraphy represents the
standard in myocardial ischemia diagnostics. On the other hand,
coronary angiography is the gold standard for the assessment of
coronary-artery disease and moreover, it has a curative potential;
the major disadvantage is the invasiveness of this method. The
latest development of a multidetector CT (up to 64 rows of detec-
tors) with 3 rotations per second achieves an isotropic spatial res-
olution of 0.4 mm and time resolution of 165 ms [4], thereby consti-
tuting a prerequisite for diagnostic coronary CT angiography (cCTA).
Thus there are two modalities, cCTA (Figure 3A) and SPECT (Fi-
gure 3B), which are capable of giving a detailed account of the
myocardial blood supply without the necessity of catheterization.
The major difference is that cCTA assesses the morphology of the
main coronary branches, while SPECT evaluates tissue perfusion
a more important aspect of myocardial function, but strongly de-
pendent on the blood flow through the coronary arteries. Both mo-
dalities could play a complementary role rather than a competitive
one. This opinion could be advocated by the knowledge that both
cCTA and SPECT are partially compromised by their not negligible
rate of false positive and negative findings. A combination of both
modalities could reduce doubts in some cases and lower the num-
bers of invasive coronary angiographies. An optimal therapeutic
approach could be predicted by non-invasive means.
These ideas open the field for image fusion of perfusion SPECT
and cCTA. The technology is already available, but its implemen-
tation into daily routine will take time. Very fast CT scanners (even
stand-alone) are still not common, the first hybrid SPECT/CT16
scanners have only been contracted, while the software to visua-
lise the coronary arteries is not automated and must be operated
by a skilled physician. The nature of such visualisation is extreme-
ly complex and it is not easy to present a hybrid 3D perfusion
model of the myocardium and the extracted vessels on its sur-
face (Figure 3C). There are as yet few qualified personnel capa-
ble of operating both modalities, and it might prove problematic
to attract skilled radiologists to nuclear medicine, as it might also
be a problem to train nuclear physicians in cCTA.
The difficulties we have mentioned above are challenging. The
first hybrid SPECT/CT16 scanner is already on the market. Close
collaboration between radiologists and nuclear physicians or even
cross-training in both specializations has already begun thanks
to the growing spread of PET/CT. The future will show whether the
benefits of hybrid SPECT/cCTA will prevail over its cost and over-
all complexity. We believe that this proposed method is in the
same situation as hybrid PET/CT was only a few years ago. Now-
adays PET/CT has completely prevailed over PET in the field of
oncology and we can look forward to a similar future for SPECT/
/cCTA.
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